Related Experiment Video
Updated: Jul 24, 2025

Drug-Induced Sleep Endoscopy DISE with Target Controlled Infusion TCI and Bispectral Analysis in Obstructive Sleep Apnea
Published on: December 6, 2016
Obstructive sleep apnea in children with Down syndrome: contribution of upper airway and chemosensitivity
Plamen Bokov1, Imene Boujemla2, Jacques Dahan3
1Université de Paris-Cité, AP-HP, Hôpital Robert Debré, Service de Physiologie Pédiatrique-Centre du Sommeil, INSERM NeuroDiderot, F-75019, Paris, France. plamen.bokov@aphp.fr.
Insights
Children with Down syndrome (DS) and obstructive sleep apnea syndrome (OSAS) have smaller airways and reduced peripheral chemosensitivity, leading to hypoventilation. This study compared airway size and ventilatory control in children with DS versus typically developing children with OSAS.
Area of Science:
- Pediatric Pulmonology
- Genetics and Genetic Disorders
- Sleep Medicine
Background:
- Obstructive sleep apnea syndrome (OSAS) is highly prevalent in children with Down syndrome (DS), often linked to reduced upper airway size.
- The contribution of ventilatory control to OSAS in DS remains unclear.
Purpose of the Study:
- To compare upper airway dimensions in children with DS and moderate-to-severe OSAS against typically developing (TD) children with similar OSAS severity.
- To evaluate modifications in chemical loop gain (LG), including controller gain (CG) and plant gain (PG), in children with DS.
Main Methods:
- A case-control study matched 13 children with DS to 26 TD children based on age, sex, OSAS severity, and ethnicity.
- Methods included acoustic rhinometry, pharyngometry, awake tidal breathing measurements for chemical LG, and hypercapnic-hyperoxic ventilatory response testing.
Main Results:
- Children with DS showed reduced oropharyngeal dimensions compared to TD children.
- Significantly lower controller gain (CG) and loop gain (LG) were observed in children with DS, while plant gain (PG) was not different.
- Hypercapnic ventilatory response slopes did not differ between the groups.
Conclusions:
- Decreased CG in DS is linked to reduced peripheral chemoreceptor sensitivity, explaining increased end-tidal PCO2 and alveolar hypoventilation.
- Pharyngeal dimensions are reduced in children with DS and OSAS.
- Results suggest autonomic nervous system dysfunction in Down syndrome.
Background:
The high prevalence of obstructive sleep apnea syndrome (OSAS) in children with Down syndrome (DS) has been attributed to a reduced upper airway size, while the role of ventilatory control is unclear. The objectives of our case-control study were to evaluate the upper airway reduction in children with DS and moderate to severe OSAS as compared to typically developing (TD) children with similar OSAS severity and to evaluate the degree of chemical loop gain modifications including its components: controller and plant gains (CG, PG).
Methods:
Thirteen children with DS were matched for age, sex, OSAS severity and ethnicity with 26 TD children. They had undergone acoustic rhinometry and pharyngometry, chemical LG obtained during awake tidal breathing measurement and hypercapnic-hyperoxic ventilatory response testing.
Results:
As compared to TD, children with DS depicted reduced oropharyngeal dimensions, significantly lower CG and LG and no different PG. Their hypercapnic ventilatory response slopes were not different.
Conclusions:
We concluded that the decreased CG in DS was related to decreased peripheral chemoreceptor sensitivity, and while central chemosensitivity was normal, the former explained the increased end-tidal PCO2 observed in children with DS as compared to TD. Pharyngeal dimensions are reduced in children with DS and OSAS.
Impact:
Reduced upper airway size and nocturnal alveolar hypoventilation in children with Down syndrome (DS) have been previously reported. We confirmed that children with DS and moderate-to-severe OSA have reduced oropharyngeal size as compared to typically developing children with similar OSAS severity and demonstrated decreased peripheral chemosensitivity explaining the alveolar hypoventilation observed in children with DS. Central chemosensitivity appears to be intact in children with DS and moderate to severe OSAS Our results support growing evidence that Down syndrome is associated with autonomic nervous system dysfunction.
More Related Videos
Related Concept Videos
Sleep Apnea
The condition is more prevalent among...
Other Pulmonary Disorders
Breathing
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation
Assessment of Airway, Skin Color, and Use of Accessory Muscles
Introduction
The initial evaluation of a patient's respiratory system...
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla. Benzonatate operates peripherally within the respiratory tract by...

